Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.9333
+0.0208 (2.28%)
May 13, 2026, 10:16 AM EDT - Market open
Jasper Therapeutics Employees
Jasper Therapeutics had 22 employees as of December 31, 2025. The number of employees decreased by 42 or -65.63% compared to the previous year.
Employees
22
Change
-42
Growth
-65.63%
Revenue / Employee
n/a
Profits / Employee
-$3,445,500
Market Cap
26.13M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 22 | -42 | -65.63% |
| Sep 30, 2025 | 27 | -37 | -57.81% |
| Dec 31, 2024 | 64 | 19 | 42.22% |
| Dec 31, 2023 | 45 | 10 | 28.57% |
| Dec 31, 2022 | 35 | 10 | 40.00% |
| Sep 30, 2022 | 36 | 14 | 63.64% |
| Jun 30, 2022 | 35 | 11 | 45.83% |
| Mar 31, 2022 | 34 | 12 | 54.55% |
| Dec 31, 2021 | 25 | 3 | 13.64% |
| Sep 30, 2021 | 22 | - | - |
| Jun 30, 2021 | 24 | - | - |
| Mar 31, 2021 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 59 |
| Longeveron | 38 |
| Kyntra Bio | 34 |
| ABVC BioPharma | 19 |
| Outlook Therapeutics | 17 |
| Barinthus Biotherapeutics | 14 |
| Allarity Therapeutics | 8 |
| Neuphoria Therapeutics | 8 |
JSPR News
- 6 weeks ago - Jasper Therapeutics price target lowered to $7 from $12 at Evercore ISI - TheFly
- 6 weeks ago - Jasper Therapeutics reports Q4 EPS (32c), consensus (82c) - TheFly
- 6 weeks ago - Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 weeks ago - Jasper Therapeutics assumed with a Neutral at UBS - TheFly
- 2 months ago - Jasper Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Jasper Therapeutics to Present at 46th Annual TD Cowen Healthcare Conference - GlobeNewsWire
- 4 months ago - Jasper Therapeutics initiated with a Buy at Rodman & Renshaw - TheFly
- 4 months ago - Jasper Therapeutics Transcript: Study Result - Transcripts